Associated Papers
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.
Nguyen V et al.
Neuro-oncology, 2012
A novel apolipoprotein E5 variant with a 24-bp insertion causing hyperlipidemia.
Yamanouchi Y et al.
Journal of Human Genetics, 2001
Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation.
Plugariu CG et al.
Biochemistry, 2000
Mutants of interleukin 13 with altered reactivity toward interleukin 13 receptors.
Thompson JP et al.
The Journal of Biological Chemistry, 1999
The cell surface expression level of the human interleukin-5 receptor alpha subunit determines the agonistic/antagonistic balance of the human interleukin-5 E13Q mutein.
Van Ostade X et al.
European Journal of Biochemistry, 1999
Select a paper to view details